Prostaglandin E2 correlates with histamine production in human colorectal cancer by Cianchi, Fabio et al.
Infl amm. res. 55, Supplement 1 (2006) S81–S82
1023-3830/06/01S81-02
DOI 10.1007/s00011-005-0053-x 
Infl ammation Research
© Birkhäuser Verlag, Basel, 2006
Prostaglandin E2 correlates with histamine production in human 
colorectal cancer
F. Cianchi1, C. Cortesini1, F. Perna1, V. Fabbroni2, C. Uliva3, F. Fabrizi3, L. Giannini3, A. Vannacci 3 and E. Masini 3
1
 Departments of General Surgery
2
 Department of Oncology, Careggi General Hospital, Florence, Italy, Fax: ++39 055 4271280, e-mail: emanuela.masini@unifi .it
3
 Preclinical and Clinical Pharmacology, University of Florence
Introduction
Histamine plays a pivotal role in a number of processes, in-
cluding infl ammation, allergic reaction, gastric acid secretion 
and neurotransmission. Expression of histidine decarboxyla-
se (HDC), the key enzyme in the synthesis of histamine, has 
been shown to be increased in colorectal carcinoma [1] and 
other types of human tumors, suggesting that histamine may 
be directly involved in tumor development and progression. 
Histamine has been shown to stimulate the in vitro and in 
vivo growth of gastrointestinal cancer cells while treatment 
with cimetidine, an H2 receptor antagonist, can reverse this 
effect [2]. Histamine also seems to be involved in the inhibi-
tion of local immune response against cancer. At increased 
pathophysiological concentrations histamine can exert po-
tent immunosuppressive effects by activating T cell suppres-
sor function and inhibiting lymphocyte proliferation [3, 4].
In the present study, we addressed the hypothesis that ac-
tivation of the COX-2 pathway mediates the possible link 
between histamine and colorectal cancer.
Materials and methods
Patients and tissue collection
Tissue samples were obtained from 33 patients (15 males, 18 females, 
median age 65 years) who had consecutively undergone surgical resec-
tions for primary sporadic colorectal adenocarcinomas at the Depart-
ment of General Surgery, University of Florence, Italy. The patients 
had not undergone any chemotherapy or other chronic pharmacological 
treatment. All patients were informed about the aims of the study and 
gave written consent for the investigation in accordance with the ethical 
guidelines of our University. Tumors were classifi ed into four stages ac-
cording to the AJCC staging system. Tissues from the edge of the tumor 
and normal mucosa 10 cm away from the tumor were excised from each 
patient. The samples were washed in PBS and frozen at –80°C until use; 
other samples were fi xed in 4 % formaldehyde and embedded in paraffi n 
for immunostaining as previously described [5].
Biochemical determinations
Histamine content was determined after butanol/heptan tissue extrac-
tion, using a previously reported fl uorimetric method [6]. PGE2 produc-
tion was measured using 100 µl of the supernatant of tissue homogenate 
using a competitive enzyme immunoassay kit (Cayman Chemical Co, 
Ann Arbor, MI, USA) according to a previously described method [7]. 
Cyclic AMP (cAMP) levels were measured in the aqueous phase of tis-
sue homogenates extracted from 10 % trichloroacetic acid with 0.5 mol/
L tri-N-octylamine dissolved in 1,1,2-trichlorofl uoroethane. cAMP was 
measured with commercially available radioimmunoassay.
Statistical analysis
Histamine, PGE2 and cAMP content were expressed as mean values +/
–standard error of mean (SEM). The extent of tumor infi ltration by lym-
phocytes was classifi ed as absent/little, moderate and diffuse. The rela-
tionships among histamine content, PGE2 production and lymphocyte 
infi ltrate were evaluated using the Spearmann correlation coeffi cient (rs). 
P values less than .05 were considered statistically signifi cant.
Results and discussion
Histamine content was signifi cantly higher in the tumor 
specimens than in the corresponding normal mucosa and 
was also higher in tumors with lymph node and/or distant 
metastases (stage III–IV) than in those without any metas-
tases (stage I–II) as we have previously reported [8]. Our 
present results evidentiated a signifi cant correlation between 
histamine content and PGE2 production (Fig.1A). We also 
found a signifi cant correlation between histamine content 
and cAMP production (rs = 0.3.5, p = 0.02) in tumor samples. 
Our results showed also that the extent of intratumor lym-
phocyte infi ltrate increased as histamine content decreased 
(Fig. 1B).
Our study shows that high levels of histamine content 
are correlated with the presence of lymph node and/or distal 
metastases in colorectal cancer. Moreover we found a signifi -Correspondence to: E. Masini
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cant correlation between these parameters and PGE2 levels as 
well as between histamine and tumor production of cAMP 
that is one of the most important intracellular mediators of 
PGE2.
Much experimental evidence demonstrates the close 
involvement of COX-2 activity and thus, PGE2 production, 
in tumor proliferation and progression [5]. Histamine has 
been reported to have an immunosuppressive effect through 
negative regulation of helper T-cell functions [3, 4]. The 
presence of tumor infi ltrating lymphocytes within colorectal 
tumor tissues is considered to be a marker of good prognosis; 
histamine content is inversely correlated with the extent of 
intratumor lymphocyte infi ltrate.
Although we did not address the mechanisms by which 
histamine may modulate immune response, our fi ndings sup-
port the hypothesis that histamine may negatively regulate 
lymphocyte proliferation and chemotaxis in the tumor mi-
croenvironment.
In conclusion, our fi ndings supported the hypothesis that 
the high histamine content of tumor may represent one of the 
underlying causes of local decreased immune surveillance 
against colon cancer.
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Fig. 1. Histamine content sig-
nifi cantly correlated with PGE2 
production (A) and decreased 
as the extent of intratumor lym-
phocyte infi ltrate increased (B). 
Histamine was expressed as ng 
per µg protein; PGE2 produc-
tion was expressed as µg per mg 
protein.
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